Neo Health Senna Syrup
Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
Public Assessment Report
(PAR)
15-05-2019
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
Senna leaf dry, Quantity: 2.5 mg/mL (Equivalent: hydroxyanthracene glycosides calculated as sennoside B, Qty 1.5 mg/mL)
Available from:
Neo Health (OTC) Pty Ltd
Pharmaceutical form:
Oral Liquid, solution
Composition:
Excipient Ingredients: xanthan gum; maltitol; methyl hydroxybenzoate; propyl hydroxybenzoate; potassium sorbate; simethicone; citric acid; Flavour
Administration route:
Oral
Therapeutic indications:
Decrease/reduce/relieve constipation
Product summary:
Visual Identification: ;
Authorization status:
Listed
Authorization date:
2018-03-16
